Advertisement
Biological Psychiatry
Advanced searchSave search
Archival Report|Articles in Press

Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

Published:November 09, 2022DOI:https://doi.org/10.1016/j.biopsych.2022.11.002
Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood
Previous ArticleAbnormally Enhanced Midfrontal Theta-Band Activity During Response Monitoring in Youth with Obsessive-Compulsive Disorder
Next ArticleAssociated genetics and connectomic circuitry in schizophrenia and bipolar disorder

      Abstract

      Background

      Neurodegenerative diseases are among the most prevalent and devastating neurological disorders, with few effective prevention and treatment strategies. We aimed to integrate genetic and proteomic data to prioritize drug targets for neurodegenerative diseases.

      Methods

      We screened human proteomes through Mendelian randomization to identify causal mediators of Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis, frontotemporal dementia, and Lewy body dementia. For instruments, we used brain and blood protein quantitative trait loci identified from one genome-wide association study with 376 participants and another with 3301 participants, respectively. Causal associations were subsequently validated by sensitivity analyses and colocalization. The safety and druggability of identified targets were also evaluated.

      Results

      Our analyses showed targeting BIN1, GRN, and RET levels in blood as well as ACE, ICA1L, MAP1S, SLC20A2, and TOM1L2 levels in brain might reduce Alzheimer’s disease risk, while ICA1L, SLC20A2, and TOM1L2 were not recommended as prioritized drugs due to the identified potential side effects. Brain CD38, DGKQ, GPNMB, and SEC23IP were candidate targets for Parkinson’s disease. Among them, GPNMB was the most promising target for Parkinson’s disease with their causal relationship evidenced by studies on both brain and blood tissues. Interventions targeting FCRL3, LMAN2, and MAPK3 in blood and DHRS11, FAM120B, SHMT1, and TSFM in brain might affect multiple sclerosis risk. The risk of amyotrophic lateral sclerosis might be reduced by medications targeting DHRS11, PSMB3, SARM1, and SCFD1 in brain.

      Conclusions

      Our study prioritized 22 proteins as targets for neurodegenerative diseases and provided preliminary evidence for drug development. Further studies are warranted to validate these targets.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Villoslada P.
        • Baeza-Yates R.
        • Masdeu J.C.
        Reclassifying neurodegenerative diseases.
        Nat Biomed Eng. 2020; 4: 759-760
        View in Article
        • The Lancet Neurology
        Joining forces to fight neurodegenerative diseases.
        Lancet Neurol. 2013; 12: 119
        View in Article
        • Alteri E.
        • Guizzaro L.
        Be open about drug failures to speed up research.
        Nature. 2018; 563: 317-319
        View in Article
        • Nelson M.R.
        • Tipney H.
        • Painter J.L.
        • Shen J.
        • Nicoletti P.
        • Shen Y.
        • et al.
        The support of human genetic evidence for approved drug indications.
        Nat Genet. 2015; 47: 856-860
        View in Article
        • Sun B.B.
        • Maranville J.C.
        • Peters J.E.
        • Stacey D.
        • Staley J.R.
        • Blackshaw J.
        • et al.
        Genomic atlas of the human plasma proteome.
        Nature. 2018; 558: 73-79
        View in Article
        • Robins C.
        • Liu Y.
        • Fan W.
        • Duong D.M.
        • Meigs J.
        • Harerimana N.V.
        • et al.
        Genetic control of the human brain proteome.
        Am J Hum Genet. 2021; 108: 400-410
        View in Article
        • Zhou S.
        • Butler-Laporte G.
        • Nakanishi T.
        • Morrison D.R.
        • Afilalo J.
        • Afilalo M.
        • et al.
        A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity.
        Nat Med. 2021; 27: 659-667
        View in Article
        • Bennett D.A.
        • Buchman A.S.
        • Boyle P.A.
        • Barnes L.L.
        • Wilson R.S.
        • Schneider J.A.
        Religious Orders Study and Rush Memory and Aging Project.
        J Alzheimers Dis. 2018; 64: S161-S189
        View in Article
        • Wingo A.P.
        • Liu Y.
        • Gerasimov E.S.
        • Gockley J.
        • Logsdon B.A.
        • Duong D.M.
        • et al.
        Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis.
        Nat Genet. 2021; 53: 143-146
        View in Article
        • Higginbotham L.
        • Ping L.
        • Dammer E.B.
        • Duong D.M.
        • Zhou M.
        • Gearing M.
        • et al.
        Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease.
        Sci Adv. 2020; 6: eaaz9360
        View in Article
        • Suhre K.
        • Arnold M.
        • Bhagwat A.M.
        • Cotton R.J.
        • Engelke R.
        • Raffler J.
        • et al.
        Connecting genetic risk to disease end points through the human blood plasma proteome [published correction appears in Nat Commun 2017; 8:15345].
        Nat Commun. 2017; 814357
        View in Article
        • Emilsson V.
        • Ilkov M.
        • Lamb J.R.
        • Finkel N.
        • Gudmundsson E.F.
        • Pitts R.
        • et al.
        Co-regulatory networks of human serum proteins link genetics to disease.
        Science. 2018; 361: 769-773
        View in Article
        • Battle A.
        • Brown C.D.
        • Engelhardt B.E.
        • Montgomery S.B.
        Genetic effects on gene expression across human tissues.
        Nature. 2017; 550: 204-213
        View in Article
        • Schwartzentruber J.
        • Cooper S.
        • Liu J.Z.
        • Barrio-Hernandez I.
        • Bello E.
        • Kumasaka N.
        • et al.
        Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes.
        Nat Genet. 2021; 53: 392-402
        View in Article
        • Nalls M.A.
        • Blauwendraat C.
        • Vallerga C.L.
        • Heilbron K.
        • Bandres-Ciga S.
        • Chang D.
        • et al.
        Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: A meta-analysis of genome-wide association studies.
        Lancet Neurol. 2019; 18: 1091-1102
        View in Article
        • van Rheenen W.
        • van der Spek R.A.A.
        • Bakker M.K.
        • van Vugt J.
        • Hop P.J.
        • Zwamborn R.A.J.
        • et al.
        Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
        Nat Genet. 2021; 53: 1636-1648
        View in Article
        • International Multiple Sclerosis Genetics Consortium
        Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.
        Science. 2019; 365eaav7188
        View in Article
        • Ferrari R.
        • Hernandez D.G.
        • Nalls M.A.
        • Rohrer J.D.
        • Ramasamy A.
        • Kwok J.B.J.
        • et al.
        Frontotemporal dementia and its subtypes: A genome-wide association study.
        Lancet Neurol. 2014; 13: 686-699
        View in Article
        • Chia R.
        • Sabir M.S.
        • Bandres-Ciga S.
        • Saez-Atienzar S.
        • Reynolds R.H.
        • Gustavsson E.
        • et al.
        Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.
        Nat Genet. 2021; 53: 294-303
        View in Article
        • Kamat M.A.
        • Blackshaw J.A.
        • Young R.
        • Surendran P.
        • Burgess S.
        • Danesh J.
        • et al.
        PhenoScanner V2: An expanded tool for searching human genotype-phenotype associations.
        Bioinformatics. 2019; 35: 4851-4853
        View in Article
        • Staley J.R.
        • Blackshaw J.
        • Kamat M.A.
        • Ellis S.
        • Surendran P.
        • Sun B.B.
        • et al.
        PhenoScanner: A database of human genotype-phenotype associations.
        Bioinformatics. 2016; 32: 3207-3209
        View in Article
        • Folkersen L.
        • Fauman E.
        • Sabater-Lleal M.
        • Strawbridge R.J.
        • Frånberg M.
        • Sennblad B.
        • et al.
        Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.
        PLoS Genet. 2017; 13e1006706
        View in Article
        • Yao C.
        • Chen G.
        • Song C.
        • Keefe J.
        • Mendelson M.
        • Huan T.
        • et al.
        Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.
        Nat Commun. 2018; 9: 3268
        View in Article
        • Yang C.
        • Farias F.H.G.
        • Ibanez L.
        • Suhy A.
        • Sadler B.
        • Fernandez M.V.
        • et al.
        Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders.
        Nat Neurosci. 2021; 24: 1302-1312
        View in Article
        • Davies N.M.
        • Holmes M.V.
        • Davey Smith G.
        Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians.
        BMJ. 2018; 362k601
        View in Article
        • Burgess S.
        • Dudbridge F.
        • Thompson S.G.
        Combining information on multiple instrumental variables in Mendelian randomization: Comparison of allele score and summarized data methods.
        Stat Med. 2016; 35: 1880-1906
        View in Article
        • Burgess S.
        • Davey Smith G.
        • Davies N.
        • Dudbridge F.
        • Gill D.
        • Glymour M.
        • et al.
        Guidelines for performing Mendelian randomization investigations [version 2; peer review: 2 approved].
        Wellcome Open Res. 2020; 4: 186
        View in Article
        • Hemani G.
        • Zheng J.
        • Elsworth B.
        • Wade K.H.
        • Haberland V.
        • Baird D.
        • et al.
        The MR-Base platform supports systematic causal inference across the human phenome.
        Elife. 2018; 7e34408
        View in Article
        • Ward L.D.
        • Kellis M.
        HaploReg: A resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants.
        Nucleic Acids Res. 2012; 40: D930-D934
        View in Article
        • Elsworth B.
        • Lyon M.
        • Alexander T.
        • Liu Y.
        • Matthews P.
        • Hallett J.
        • et al.
        The MRC IEU OpenGWAS data infrastructure.
        bioRxiv. 2020; https://doi.org/10.1101/2020.08.10.244293
        View in Article
        • Finan C.
        • Gaulton A.
        • Kruger F.A.
        • Lumbers R.T.
        • Shah T.
        • Engmann J.
        • et al.
        The druggable genome and support for target identification and validation in drug development.
        Sci Transl Med. 2017; 9eaag1166
        View in Article
        • Wishart D.S.
        • Feunang Y.D.
        • Guo A.C.
        • Lo E.J.
        • Marcu A.
        • Grant J.R.
        • et al.
        DrugBank 5.0: A major update to the DrugBank database for 2018.
        Nucleic Acids Res. 2018; 46: D1074-D1082
        View in Article
        • Emmerich C.H.
        • Gamboa L.M.
        • Hofmann M.C.J.
        • Bonin-Andresen M.
        • Arbach O.
        • Schendel P.
        • et al.
        Improving target assessment in biomedical research: The GOT-IT recommendations.
        Nat Rev Drug Discov. 2021; 20: 64-81
        View in Article
        • Kunkle B.W.
        • Grenier-Boley B.
        • Sims R.
        • Bis J.C.
        • Damotte V.
        • Naj A.C.
        • et al.
        Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
        Nat Genet. 2019; 51: 414-430
        View in Article
        • den Brok M.
        • van Dalen J.W.
        • Abdulrahman H.
        • Larson E.B.
        • van Middelaar T.
        • van Gool W.A.
        • et al.
        Antihypertensive medication classes and the risk of dementia: A systematic review and network meta-analysis.
        J Am Med Dir Assoc. 2021; 22: 1386-1395.e1315
        View in Article
        • Guan Z.
        • Chen Z.
        • Fu S.
        • Dai L.
        • Shen Y.
        Progranulin administration attenuates β-amyloid deposition in the hippocampus of 5xFAD mice through modulating BACE1 expression and microglial phagocytosis.
        Front Cell Neurosci. 2020; 14: 260
        View in Article
        • Diaz-Ortiz M.E.
        • Seo Y.
        • Posavi M.
        • Carceles Cordon M.
        • Clark E.
        • Jain N.
        • et al.
        GPNMB confers risk for Parkinson’s disease through interaction with α-synuclein.
        Science. 2022; 377eabk0637
        View in Article
        • Moloney E.B.
        • Moskites A.
        • Ferrari E.J.
        • Isacson O.
        • Hallett P.J.
        The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson’s disease patients and increases after lysosomal stress.
        Neurobiol Dis. 2018; 120: 1-11
        View in Article
        • Cui X.
        • Liu C.M.
        • Liu Q.B.
        FCRL3 promotes IL-10 expression in B cells through the SHP-1 and p38 MAPK signaling pathways.
        Cell Biol Int. 2020; 44: 1811-1819
        View in Article
        • Endo S.
        • Miyagi N.
        • Matsunaga T.
        • Hara A.
        • Ikari A.
        Human dehydrogenase/reductase (SDR family) member 11 is a novel type of 17β-hydroxysteroid dehydrogenase.
        Biochem Biophys Res Commun. 2016; 472: 231-236
        View in Article
        • Deeb O.
        • Nabulsi M.
        Exploring multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) as neurodegenerative diseases and their treatments: A review study.
        Curr Top Med Chem. 2020; 20: 2391-2403
        View in Article
        • Zheng J.
        • Haberland V.
        • Baird D.
        • Walker V.
        • Haycock P.C.
        • Hurle M.R.
        • et al.
        Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.
        Nat Genet. 2020; 52: 1122-1131
        View in Article
        • Kia D.A.
        • Zhang D.
        • Guelfi S.
        • Manzoni C.
        • Hubbard L.
        • Reynolds R.H.
        • et al.
        Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets.
        JAMA Neurol. 2021; 78: 464-472
        View in Article

      Article info

      Publication history

      Published online: November 09, 2022
      Accepted: November 2, 2022
      Received in revised form: October 29, 2022
      Received: May 12, 2022

      Publication stage

      In Press Journal Pre-Proof

      Footnotes

      The International FTD-Genetics Consortium (IFGC): Raffaele Ferrari, Dena G. Hernandez, Michael A. Nalls, Jonathan D. Rohrer, Adaikalavan Ramasamy, John B.J. Kwok, Carol Dobson-Stone, William S. Brooks, Peter R. Schofield, Glenda M. Halliday, John R. Hodges, Olivier Piguet, Lauren Bartley, Elizabeth Thompson, Eric Haan, Isabel Hernández, Agustín Ruiz, Mercè Boada, Barbara Borroni, Alessandro Padovani, Carlos Cruchaga, Nigel J. Cairns, Luisa Benussi, Giuliano Binetti, Roberta Ghidoni, Gianluigi Forloni, Daniela Galimberti, Chiara Fenoglio, Maria Serpente, Elio Scarpini, Jordi Clarimón, Alberto Lleó, Rafael Blesa, Maria Landqvist Waldö, Karin Nilsson, Christer Nilsson, Ian R.A. Mackenzie, Ging-Yuek R. Hsiung, David M.A. Mann, Jordan Grafman, Christopher M. Morris, Johannes Attems, Timothy D. Griffiths, Ian G. McKeith, Alan J. Thomas, P. Pietrini, Edward D. Huey, Eric M. Wassermann, Atik Baborie, Evelyn Jaros, Michael C. Tierney, Pau Pastor, Cristina Razquin, Sara Ortega-Cubero, Elena Alonso, Robert Perneczky, Janine Diehl-Schmid, Panagiotis Alexopoulos, Alexander Kurz, Innocenzo Rainero, Elisa Rubino, Lorenzo Pinessi, Ekaterina Rogaeva, Peter St. George-Hyslop, Giacomina Rossi, Fabrizio Tagliavini, Giorgio Giaccone, James B. Rowe, Johannes C.M. Schlachetzki, James Uphill, John Collinge, Simon Mead, Adrian Danek, Vivianna M. Van Deerlin, Murray Grossman, John Q. Trojanowski, Julie van der Zee, William Deschamps, Tim Van Langenhove, Marc Cruts, Christine Van Broeckhoven, Stefano F. Cappa, Isabelle Le Ber, Didier Hannequin, Véronique Golfier, Martine Vercelletto, Alexis Brice, Benedetta Nacmias, Sandro Sorbi, Silvia Bagnoli, Irene Piaceri, Jørgen E. Nielsen, Lena E. Hjermind, Matthias Riemenschneider, Manuel Mayhaus, Bernd Ibach, Gilles Gasparoni, Sabrina Pichler, Wei Gu, Martin N. Rossor, Nick C. Fox, Jason D. Warren, Maria Grazia Spillantini, Huw R. Morris, Patrizia Rizzu, Peter Heutink, Julie S. Snowden, Sara Rollinson, Anna Richardson, Alexander Gerhard, Amalia C. Bruni, Raffaele Maletta, Francesca Frangipane, Chiara Cupidi, Livia Bernardi, Maria Anfossi, Maura Gallo, Maria Elena Conidi, Nicoletta Smirne, Rosa Rademakers, Matt Baker, Dennis W. Dickson, Neill R. Graff-Radford, Ronald C. Petersen, David Knopman, Keith A. Josephs, Bradley F. Boeve, Joseph E. Parisi, William W. Seeley, Bruce L. Miller, Anna M. Karydas, Howard Rosen, John C. van Swieten, Elise G.P. Dopper, Harro Seelaar, Yolande A.L. Pijnenburg, Philip Scheltens, Giancarlo Logroscino, Rosa Capozzo, Valeria Novelli, Annibale A. Puca, Massimo Franceschi, Alfredo Postiglione, Graziella Milan, Paolo Sorrentino, Mark Kristiansen, Huei-Hsin Chiang, Caroline Graff, Florence Pasquier, Adeline Rollin, Vincent Deramecourt, Florence Lebert, Dimitrios Kapogiannis, Luigi Ferrucci, Stuart Pickering-Brown, Andrew B. Singleton, John Hardy, Parastoo Momeni.

      Identification

      DOI: https://doi.org/10.1016/j.biopsych.2022.11.002

      Copyright

      © 2022 Society of Biological Psychiatry.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX